🔬 This facility enhances assay capabilities for biologics, RNA therapeutics, and vaccines, under GMP standards.
🛠️ Key services include custom potency assay development and GMP-compliant testing.
📈 The center aims to provide precise and reproducible potency data for advanced therapies.
Introduction:
The recent inauguration of Avance Biosciences’ Potency and Cell-Based Assay Center of Excellence signifies a substantial advancement in the company’s capabilities to conduct potency and functional cell-based assays compliant with Good Manufacturing Practices (GMP). This initiative aims to bolster support for the development and manufacturing of biologics and advanced therapeutics.
- The new Center is specifically designed to centralize and enhance the company’s potency and cell-based assay capabilities, positioned in Houston, Texas.
- Key services offered by the Center include custom potency assay development, qualification and validation of assays according to regulatory standards, and standardized sample testing for clinical and commercial purposes.
- The facility is equipped with state-of-the-art instrumentation and staffed by specialists in cell biology and assay development.
- Dr. Xuening (James) Huang, CEO, emphasizes the Center’s role in producing precise, reproducible, and scientifically robust potency data to support diverse therapeutic modalities.
- The centralized efforts within the new facility are expected to lead to faster turnaround times and improved workflow standardization, benefiting a broad range of therapeutic platforms, including monoclonal antibodies and gene therapies.
Conclusion:
The establishment of Avance Biosciences’ Potency and Cell-Based Assay Center of Excellence not only enhances its analytical and bioanalytical capacities but also exemplifies the company’s commitment to advancing therapeutic development through reliable potency assays. This strategic investment is poised to significantly support clients in navigating the complexities of modern biologics and next-generation therapeutics.
